NuVasive, Inc. Buyback
OLI recorded this information on 10/24/2017
Company:
NuVasive, Inc.
Buyback:
NUVA buyback
$Amount Authorized:
$100,000,000
Buyback Details:
NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that its Board of Directors approved a share repurchase program authorizing the purchase of up to $100 million of the Company's common stock over a three-year period commencing October 25, 2017.
Nuvasive is a medical technology company focused on developing, manufacturing, selling and providing procedural solutions for spine surgery, with a guiding purpose to transform surgery, develop and change lives. Co. provides portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. In addition, Co. develops and sells magnetically adjustable implant systems for spine and orthopedic procedures. Co. also designs and sells expandable growing rod implant systems for the treatment of early-onset scoliosis.
Open the NUVA Page at The Online Investor »
|
||||||||||||
Open the NUVA Page at The Online Investor (in a new window) »
 Free NUVA Email Alerts:
Get SEC Filing Alerts Get Dividend Alerts 
|
Avg. Broker Rec.
  
|
Buy (2.54 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Analysts' Target Price: NUVA Stock Forecast Based on Zacks ABR data; powered by Xignite |
